Top compounds associated with response to EIF2B3


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC 0.084 0.02
mRNA paclitaxel CCLE pan-cancer AAC 0.1 0.02
mRNA BMS-754807 FIMM pan-cancer AAC -0.3 0.02
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.086 0.02
mRNA TW 37 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA PD-0332991 FIMM pan-cancer AAC -0.38 0.02
mRNA Imatinib CTRPv2 pan-cancer AAC 0.083 0.02
mRNA semagacestat CTRPv2 pan-cancer AAC -0.084 0.02
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.16 0.03
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.086 0.03
Download CSV